4.7 Letter

ETV6-NTRK3 induces aggressive acute lymphoblastic leukemia highly sensitive to selective TRK inhibition

Journal

BLOOD
Volume 132, Issue 8, Pages 861-865

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2018-05-849554

Keywords

-

Categories

Funding

  1. National Institutes of Health, National Cancer Institute Comprehensive Cancer Center [CA012765, R35CA197695]
  2. American Society of Hematology Scholar Award
  3. St. Baldrick's Foundation Scholar Award
  4. Robert J. Arceci Innovation Award
  5. Henry Schueler 41 9 Foundation
  6. Leukemia and Lymphoma Society Specialized Center of Research grant
  7. St. Baldrick's Foundation Consortium Award
  8. Loxo Oncology
  9. American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available